Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Riboflavin 5'-Phosphate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 known ✓ | P04150 | 1/20 | 0.84 |
| ▸ | PTGS2 known ✓ | P35354 | 1/20 | 0.84 |
| ▸ | TST | Q16762 | 2/20 | 0.88 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.88 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.88 |
| ▸ | ESR1 | P03372 | 1/20 | 0.84 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.84 |
| ▸ | HTR2C | P28335 | 1/20 | 0.84 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.84 |
| ▸ | MEN1 | O00255 | 7/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.72 |
| ▸ | USP2 | O75604 | 4/20 | 0.72 |
| ▸ | HTT | P42858 | 4/20 | 0.72 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.72 |
| ▸ | HAT1 | O14929 | 4/20 | 0.72 |
| ▸ | RBBP7 | Q16576 | 4/20 | 0.72 |
| ▸ | RECQL | P46063 | 3/20 | 0.72 |
| ▸ | CASP7 | P55210 | 3/20 | 0.72 |
| ▸ | MAPT | P10636 | 3/20 | 0.72 |
| ▸ | CASP1 | P29466 | 2/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Riboflavin 5'-Phosphate SCHEMBL18762353 | 0.99 | TST (0.90) | TSTHSPD1HSPE1ESR1NR3C1 | |
| Riboflavin 5'-Phosphate SCHEMBL26122 | 0.95 | TST (0.98) | TSTHSPD1HSPE1ESR1NR3C1 | |
| Riboflavin 5'-Phosphate SCHEMBL8656633 | 0.95 | TST (0.98) | TSTHSPD1HSPE1ESR1NR3C1 | |
| Riboflavin 5'-Phosphate SCHEMBL623880 | 0.95 | TST (0.98) | TSTHSPD1HSPE1ESR1NR3C1 | |
| Riboflavin 5'-Phosphate SCHEMBL1232070 | 0.94 | TST (0.97) | TSTHSPD1HSPE1ESR1NR3C1 | |
| Riboflavin 5'-Phosphate SCHEMBL29738641 | 0.94 | TST (1.00) | TSTHSPD1HSPE1ESR1NR3C1 | |
| Riboflavin 5'-Phosphate SCHEMBL21899339 | 0.94 | TST (1.00) | TSTHSPD1HSPE1ESR1NR3C1 | |
| Riboflavin 5'-Phosphate SCHEMBL29456702 | 0.94 | TST (1.00) | TSTHSPD1HSPE1ESR1NR3C1 | |
| Riboflavin 5'-Phosphate SCHEMBL29839430 | 0.94 | TST (1.00) | TSTHSPD1HSPE1ESR1NR3C1 | |
| Riboflavin 5'-Phosphate SCHEMBL41133 | 0.92 | ESR1 (1.00) | TSTHSPD1HSPE1ESR1NR3C1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 553 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260061056-A1 | RINSE SOLUTION FOR A PHOTODYNAMIC DISINFECTION | MANA HEALTH TECHNOLOGIES GMBH (AT) | 2026-03-05 | — | — | US | claimed |
| US-20250345480-A1 | Bioink Compositions and Methods for 3D Printing Of Vascularized Tissue Constructs | UNIV WAKE FOREST HEALTH SCIENCES (US) | 2025-11-13 | — | — | US | claimed |
| US-12384701-B2 | Ion removal devices based on electrochemistry and photo-electrochemistry, and preparation method and application | SOUTH CHINA NORMAL UNIVERSITY (CN) | 2025-08-12 | — | — | US | claimed |
| EP-4019646-B1 | METHODS AND KITS FOR DETECTING SPERM DNA FRAGMENTATION | BONRAYBIO CO LTD (TW) | 2025-06-11 | — | — | EP | claimed |
| EP-4525996-A1 | RINSE SOLUTION FOR A PHOTODYNAMIC DISINFECTION | Mana Health Technologies GmbH (AT) | 2025-03-26 | — | — | EP | claimed |
| WO-2023222316-A1 | RINSE SOLUTION FOR A PHOTODYNAMIC DISINFECTION | MANA HEALTH TECHNOLOGIES GMBH (AT) | 2023-11-23 | — | — | WO | claimed |
| EP-4279141-A1 | RINSING SOLUTION FOR PHOTODYNAMIC DISINFECTION | Mana Health Technologies GmbH (AT) | 2023-11-22 | — | — | EP | claimed |
| WO-2023173104-A1 | PHOSPHOLIPID-CONTAINING DISCS AND METHODS OF MANUFACTURE | THORNE HEALTHTECH, INC. (US) | 2023-09-14 | — | — | WO | claimed |
| US-20230241285-A1 | Selectively Polymerizable Compositions and Methods of Use in Vivo | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2023-08-03 | — | — | US | claimed |
| US-20230142889-A1 | BIODEGRADABLE POLYMER-GELATIN HYDROGEL COMPOSITE, METHOD FOR MANUFACTURING SAME, AND MEDICAL IMPLANT COMPRISING BIODEGRADABLE POLYMER-GELATIN HYDROGEL COMPOSITE | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-05-11 | — | — | US | claimed |
| EP-2098121-A1 | GREEN TEA DRINK PACKED IN CONTAINER | Kao Corporation (JP) | 2009-09-09 | — | — | EP | claimed |
| EP-2095727-A1 | PACKED DRINK | Kao Corporation (JP) | 2009-09-02 | — | — | EP | claimed |
| US-20090191311-A1 | BEVERAGE PACKED IN FOAM CONTAINER | KAO CORPORATION (JP) | 2009-07-30 | — | — | US | claimed |
| EP-2036446-A1 | BEVERAGE PACKED IN FOAM CONTAINER | KAO CORPORATION (JP) | 2009-03-18 | — | — | EP | claimed |
| EP-1712140-B1 | Food product for prevention of fragility syndrome with elderly people | LARENA (FR) | 2008-08-20 | — | — | EP | claimed |
| US-20080038408-A1 | PACKAGED BEVERAGES | KAO CORPORATION (JP) | 2008-02-14 | — | — | US | claimed |
| WO-2007019378-A2 | METHOD OF TREATING NEUROLOGICAL DISORDERS | BALDINGER ESTHER | 2007-02-15 | — | — | WO | claimed |
| US-20070031394-A1 | Method of treating neurological disorders | BALDINGER ESTHER | 2007-02-08 | — | — | US | claimed |
| EP-0523582-B1 | Improved process for preparing riboflavin 5'-phosphate ester monosodium salt | BASF AG (DE) | 1998-10-14 | — | — | EP | claimed |
| US-4167562-A | Method and composition for treating arteriosclerosis | EVERS H RAY | 1979-09-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260061056-A1 | RINSE SOLUTION FOR A PHOTODYNAMIC DISINFECTION | PRPS1, UROD, PDE6D | NR3C1 4846/4885PTGS2 1308/4885TST 1215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.